Abstract
Suitability Petition (SP) is a petition (request) to Food and Drug Administration to permit the filing of an Abbreviated New Drug Application for a drug that differs from the Reference Listed Drug. According to FDA, response timeline is 90 days. While submitting the Suitability petition to the FDA the applicant should submit in the following format: a) Action Requested, b) Statement of Grounds, c) Environmental Assessment d) Economic Impact e) Certification by applicant. A type of citizen petition submitted in compliance with 21 CFR 10.30 requesting FDA to approve or disapprove a specific change. If FDA approves a SP, the generic manufacturer can file for approval of ANDA or 505(b) 2 or 351k application for the requested change. Suitability Petition contains information of the RLD and Proposed change (Comparisons) by Generics.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.